Bausch & Lomb acquisition complete, stock ceases trading

By Lisa Kerner

Charlotte, N.C., Oct. 26 - Warburg Pincus, LLC completed its $4.5 billion acquisition of Bausch & Lomb, Inc. As a result, Bausch & Lomb stock ceased trading on the New York Stock Exchange when the market closed on Friday.

Bausch & Lomb shareholders approved the deal, which gives them $65 per share, at a special meeting on Sept. 21.

"With a strong and supportive partner in Warburg Pincus, we are well-positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry," Bausch & Lomb chairman and chief executive officer Ronald L. Zarrella said in a company news release.

"Our customers will continue to receive high levels of service, product quality and innovation, and our commitment to serving their needs remains steadfast," Zarrella added.

Under the previously announced agreement entered into on May 16, WP Prism Merger Sub Inc. merged with and into Bausch & Lomb, with Bausch & Lomb remaining as the surviving corporation and as a wholly owned subsidiary of WP Prism LLC.

Bausch & Lomb is an eye health company based in Rochester, N.Y.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.